Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124144) titled 'Berberine Hydrochloride Tablets for the Treatment of Irinotecan-Induced Diarrhea in Patients with Solid Tumors: A Prospective Double-Blind Randomized Controlled Study' on May 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Affiliated Hospital of Zhejiang Chinese Medical University
Condition:
Solid Tumor Patients
Intervention:
Study Group:Berberine
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-10
Target Sample Size: Study Group:53;Control group:53;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...